A glioma is a type of primary central nervous system (CNS) tumor that arises from glial cells. The most common site of involvement of a glioma is the brain, but they can also affect the spinal cord, or any other part of the CNS, such as the optic nerves.
There are numerous grading systems, but the most commonly used system is the World Health Organization (or WHO) grading system for astrocytomas. The WHO system assigns astrocytomas a grade from 1 to 4, with 1 being the least aggressive and 4 being the most aggressive. Various types of astrocytomas are given corresponding WHO grades.
The prognosis is the worst for Grade 4 gliomas, with an average survival time of 12 months. Overall, few patients survive beyond 3 years. * *
On the other hand, low grade gliomas grow slowly, often over many years, and can be followed without treatment unless they grow and cause symptoms.
A small number of low-scale clinical studies have shown possible links between prescription of Carphedon and improvement in a number of encephalopathic conditions, including lesions of cerebral blood pathways and certain types of glioma.
American scientists are also studying the affects of Leiurus Quinquestriatus scorpion (Israeli Yellow Scorpion) venom on glioma. They have successfully isolated the peptide chlorotoxin from the venom of the Leiurus Quinquestriatus scorpion by means of gel filtration chromatography. The peptide appears to target glioma-specific chloride ion channels within the cancerous glial cells of the brain, where it binds with a high affinity. Only eight people have received this treatment and seven of them are still living.
Further, lots of research is being conducted in recent years (i.e. the last few years before and including 2006). Research topics include, but are by no means limited to :
Although there have been individual cases of patients receiving an experimental treatment who still showed no signs of tumor 3 years or even more after the first diagnosis, often a new treatment for GBM will already be considered successful if it significantly increases the percentage of survivors after 2 years.
Because a lot of research has been started only recently, the long term survival chances (and long term side effects) are still unknown for many proposed experimental treatments.
The US National Institute of Health
has a database with information about recent and current studies.
For a list of current scientific investigations about glioblastoma treatment, goto Clinical Trials Search
Search tips :
Patients willing to participate in experimental studies would be well advised to discuss this with their doctor first, and try to find someone who specializes in this field. This kind of specialization is more often found in university hospitals than in smaller regional hospitals.